Angelalign's Court Ruling Impact is Minimal for Customers Despite Changes in Technology

Minimal Court Ruling Impact on Angelalign Customers



In a recent development, Angelalign Technology Inc. (6699.HK) has released a statement clarifying the implications of a ruling from the local division of the Unified Patent Court in Paris. The decision pertains to the company’s previously employed feature known as 'torque ridges', which has been determined to infringe upon Align Technology Inc.'s patents related to dental repositioning based on orthodontic treatment plans. However, Angelalign assures its customers that the impact of this ruling will be minimal, particularly in the European market.

Since September, Angelalign has proactively transitioned away from the torque ridges feature and replaced it with an upgraded technology termed 'pressure points'. This innovation is designed specifically to enhance torque control, which is crucial for effective orthodontic treatment. As a result, customers across Europe, including orthodontists in Spain and the UK, will see no disruption in the availability of Angelalign products or services. This new approach is a testament to Angelalign's commitment to innovation in addressing clinical challenges faced by orthodontists.

Xavier Cherbavaz, CEO and Vice President for Europe, Africa, and the Middle East at Angelalign Technology Inc., emphasized the company's dedication to ensuring that orthodontists maintain high standards of patient care. He stated, "Torque ridges have already been removed from our offerings; they have been replaced with pressure points, which are designed to support controlled force application and dental contact. We are focused on continuously providing orthodontists with innovative clinical solutions and reliable customer experiences."

Angelalign is positioning itself as a responsive and responsible player in the orthodontic technology space. Richard Hirschland, Chief Commercial Officer at Angelalign, reiterated the company’s respect for intellectual property rights, stating that they take such matters seriously and are evaluating the court's reasoning while considering their options moving forward. Regardless of the ongoing legal dispute with competitors, Hirschland assured that Angelalign will continue to innovate and enhance its products for the benefit of providers and their patients. The transition to the pressure points system reflects their relentless commitment to improving customer experiences and addressing orthodontic challenges promptly.

With a market capitalization close to $2 billion and having surpassed two million treated cases globally, Angelalign continues to affirm its status as a leader in providing clinically oriented solutions to transparent brace technology. Their ongoing investment in research and development underscores a long-term commitment to orthodontists and their patients, reinforcing the value they bring to the healthcare space.

For further details, visit Angelalign's Website.

This evolution in technology from Angelalign highlights the company’s proactive stance in maintaining a robust range of solutions that directly address the needs of orthodontic professionals, ensuring seamless service and excellent patient care, regardless of the legal landscapes they navigate. The company remains devoted to developing innovative solutions, securing the trust of orthodontists for the long haul.,

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.